MYRIAD GENETICS, INC. Income (Loss) from Continuing Operations, Per Diluted Share
MYRIAD GENETICS, INC. (MYGN) reported Income (Loss) from Continuing Operations, Per Diluted Share of $1.10 per share for the 12-month period ending 2011-06-30, per its 10-K filed 2011-08-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2011-08-15
- MYRIAD GENETICS, INC. income (loss) from continuing operations, per diluted share for fiscal 2011 was $1.10, a 28.57% decline from fiscal 2010.
- MYRIAD GENETICS, INC. income (loss) from continuing operations, per diluted share for fiscal 2010 was $1.54, a 11.59% increase from fiscal 2009.
- MYRIAD GENETICS, INC. income (loss) from continuing operations, per diluted share for fiscal 2009 was $1.38.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 12 month |
|---|---|
| 2011-06-30 | $1.10 10-K · filed 2011-08-15 |
| 2010-06-30 | $1.54 10-K · filed 2011-08-15 |
| 2009-06-30 | $1.38 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |